Founded as a company in 2022, Cocoon leverages a novel, automated expression system in which insects in their chrysalis stage serve as natural bioreactors. Cocoon’s R&D and Manufacturing facilities are located in Spain, where we produce high performance recombinant proteins and enzymes for healthcare and bioprocess applications at price points significantly lower than other, traditional expression systems.